Evidence-based insights into peptide protocols, safety research, and optimization strategies. Built on clinical rigor, powered by community knowledge.
Get weekly insights on peptide protocols, safety updates, and optimization strategies delivered to your inbox.
No spam. Unsubscribe anytime. Clinical rigor, always.
Comprehensive outcome research with safety data and practical protocol references
From BPC-157 to MK-677, the new science of peptide-driven body recomposition is challenging the traditional anabolic toolkit.
The era of natural mimicry is here. Peptidomimetics designed to hijack endogenous signaling cascades offer accelerated tissue repair and metabolic correction — but the myostatin paradox, oncologic unknowns, and the regulatory cat-and-mouse game demand clinical caution over marketing hype.
Evidence-graded testosterone profiles by ester and formulation, with safety data and peptide alternatives
The most prescribed testosterone ester outside the US, with a 4.5-7 day half-life that demands weekly dosing for stable levels. What the clinical data says about the hepcidin hijack, erythrocytosis, and why dosing frequency matters more than dose size.
Evidence-graded profile of testosterone enanthate: the hepcidin mechanism behind erythrocytosis, DHT and the scrotal paradox, dosing frequency pharmacokinetics, the TRAVERSE prostate saturation model, age-stratified risk, and peptide alternatives.
35+
Articles
18
Categories